PEREGRINE PHARMACEUTICALS IN's ticker is PPHMXXXX and the CUSIP is 713661304. A total of 54 filers reported holding PEREGRINE PHARMACEUTICALS IN in Q2 2017. The put-call ratio across all filers is 0.55 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $88,000 | +54.4% | 134,200 | -27.3% | 0.12% | +24.0% |
Q4 2016 | $57,000 | +307.1% | 184,700 | +475.4% | 0.10% | -3.0% |
Q3 2016 | $14,000 | -78.5% | 32,100 | -50.0% | 0.10% | +1550.0% |
Q3 2015 | $65,000 | +116.7% | 64,200 | +181.6% | 0.01% | +100.0% |
Q2 2015 | $30,000 | -18.9% | 22,800 | -17.7% | 0.00% | 0.0% |
Q1 2015 | $37,000 | -54.9% | 27,700 | -35.4% | 0.00% | -70.0% |
Q1 2014 | $82,000 | +173.3% | 42,900 | +84.1% | 0.01% | +100.0% |
Q2 2013 | $30,000 | – | 23,300 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BAXTER BROS INC | 170,506 | $232,000 | 0.09% |
First Heartland Consultants, Inc. | 86,204 | $117,000 | 0.05% |
Rotella Capital Management, Inc. | 20,769 | $28,000 | 0.03% |
FIDGEON TIMOTHY F | 33,000 | $45,000 | 0.02% |
QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 547,800 | $746,000 | 0.02% |
Freedom Investment Management, Inc. | 74,127 | $101,000 | 0.02% |
Investors Capital Advisory Services | 63,288 | $86,000 | 0.02% |
REYNOLDS CAPITAL MANAGEMENT LLC | 10,000 | $14,000 | 0.01% |
Tower Research Capital LLC (TRC) | 76,914 | $104,000 | 0.01% |
PINNACLE FINANCIAL PARTNERS INC | 20,000 | $27,000 | 0.01% |